Corresponding Author: David L. Swerdlow, MD, Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA 19426 (david.swerdlow@pfizer.com).
Published Online: May 15, 2020. doi:10.1001/jama.2020.7872
Conflict of Interest Disclosures: Dr Angulo reported being employed by Pfizer Vaccines and owning stock and stock options in Pfizer. Dr Finelli reported being employed by Merck & Co Inc and may own stock in the company. Dr Swerdlow reported being employed by Pfizer Vaccines and owning stock and stock options in Pfizer, as well as providing overviews of SARS and Middle East respiratory syndrome epidemiology to a consulting firm for a minimal honorarium.
Funding/Support: This work was supported by Pfizer.
Role of the Funder/Sponsor: Pfizer Inc reviewed the manuscript and approved the decision to submit the manuscript for publication.
2.Bennett
S , Woods
T , Liyanage
WM , Smith
DL . A simplified general method for cluster-sample surveys of health in developing countries.
World Health Stat Q. 1991;44(3):98-106.
PubMedGoogle Scholar 3.Flaxman
S , Mishra
S , Gandy
A ,
et al.
Report 13: Estimating the Number of Infections and the Impact of Non-pharmaceutical Interventions on COVID-19 in 11 European Countries. Imperial College London; March 30, 2020. doi:
10.25561/77731 6.Shrestha
SS , Swerdlow
DL , Borse
RH ,
et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010).
Clin Infect Dis. 2011;52(52)(suppl 1):S75-S82. doi:
10.1093/cid/ciq012PubMedGoogle ScholarCrossref 8.World Health Organization. Mathematical modelling of the pandemic H1N1 2009.
Wkly Epidemiol Rec. 2009;84(34):341-348.
PubMedGoogle Scholar 9.Bendavid
E , Mulaney
B , Sood
N ,
et al. COVID-19 antibody seroprevalence in Santa Clara County, California.
medRxiv. Preprint posted April 30, 2020. doi:
10.1101/2020.04.14.20062463